[1]
N. A. Tuấn, N. T. T. Hoà, L. V. Quảng, and V. H. Thanh, “First – line Afatinib treatment outcomes in stage IV non – small cell lung cancer harboring uncommon EGFR mutations at Vietnam National Cancer Hospital”, TCNCYH, vol. 204, no. 7, pp. 448-458, Aug. 2026.